Teladoc misses Q2 revenue target as BetterHelp cash-pay revenue drops 20%

Teladoc reported Q2 revenue of $607M, missing estimates by 1.5%, as BetterHelp cash-pay revenue collapsed 20%.

"We are pivoting aggressively toward insurance-covered therapy, but provider capacity constraints are hampering our ability to convert that demand into revenue fast enough," Chief Executive Officer Jason Gorevic said.

The company posted an adjusted loss of $0.21 a share, beating the $0.23 loss analysts projected. BetterHelp, Teladoc's largest mental health segment, saw cash-pay revenue decline 20% year-over-year, accelerating from prior quarters. The company slashed its full-year guidance, warning of steeper declines ahead.

Shares fell 24% in after-hours trading, erasing roughly $300M in market value. The guidance cut shows that Teladoc's transition from consumer cash-pay to insurance-covered therapy is taking longer than expected, with provider capacity constraints limiting the pace of conversion.

Metric	Actual	Consensus	Beat/Miss
Revenue	$607M	$616M	-1.5%
EPS	-$0.21	-$0.23	+$0.02

The telehealth sector faces a broader reckoning as pandemic-era demand normalization continues. Competitors Amwell and Hims & Hers are navigating similar headwinds, though Teladoc's scale in mental health makes it particularly exposed to the cash-pay slowdown. The company's insurance-covered therapy push could unlock a larger addressable market, but the near-term pain from declining consumer revenue is testing investor patience.

The guidance reduction implies management expects the BetterHelp decline to deepen before the insurance pivot gains traction. Investors will watch the Q3 earnings call for updates on provider network expansion and the pace of insurance contract conversions.

This article is for informational purposes only and does not constitute investment advice.